CDSCO

India Likely to Approve AstraZeneca Vaccine by Next Week

Serum Institute Fracas Exposes Loose Ends of India’s Clinical Trial Machinery

Serum Institute, Bharat Biotech Vaccine Candidates Emergency Okay Paused

Bharat Biotech Seeks Emergency Use Authorisation for Indigenous COVID Vaccine

The panel had also suggested that the company pay compensation of around Rs 20 lakh to the affected patients.. Credit: Reuters/File Photo

J&J Can Sell TB Drug to Minors After Govt Panel Waives Local Trials

Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque?

There Are More Questions We Need to Ask About the COVAXIN Clinical Trials